Notes from the Field: Exported Case of Sin Nombre Hantavirus Pulmonary Syndrome — Israel, 2017
Weekly / October 12, 2018 / 67(40);1129
Please note: An erratum has been published for this report. To view the erratum, please click here.
Aaron Kofman, MD1,2; Galia Rahav, MD3,4; Del Yazzie, MPH5; Herman Shorty5; Hayley D. Yaglom, MS, MPH6; Dallin Peterson, MPH7; Melissa Peek-Bullock8; Mary J. Choi, MD2; Anat Wieder-Finesod, MD3; John D. Klena, PhD2; Heather Venkat, DVM5; Cheng-Feng Chiang, PhD2; Barbara Knust, DVM2; Marlene Gaither, MPA, MSEV9; Matthew Maurer, MPH10; Donald R. Hoeschele, MS11; Stuart T. Nichol, PhD2 (View author affiliations)View suggested citation
Views equals page views plus PDF downloads
- pdf icon [PDF]
In November 2017, CDC confirmed Sin Nombre virus (SNV) infection in a previously healthy man aged 47 years who was admitted to a hospital in Israel. The patient had traveled with his family on vacation to the southwestern United States (Arizona, Nevada, and Utah) during October 3–9, 2017. During this time, he and his family hiked and biked the southern rim of the Grand Canyon and Zion National Park and took a guided tour through Antelope Cave. On November 7, approximately 3 weeks after his return to Israel, he was hospitalized with fever, cough, and shortness of breath requiring bilevel positive airway pressure. A chest radiograph indicated diffuse reticulonodular infiltrates with consolidations at the right costophrenic angle and in the retrocardiac space. Based upon the patient’s travel history and clinical findings, hantavirus pulmonary syndrome was suspected. A blood specimen collected on November 9 tested positive for SNV using nested reverse transcription–polymerase chain reaction; he had an immunoglobulin M titer of ≥1:6,400 and an immunoglobulin G titer of ≥1:6,400. Hantavirus pulmonary syndrome has a mortality rate of approximately 36%.* The patient was treated with supportive care and discharged from the hospital on November 19. No illness was reported in any family member who traveled with him.
SNV is a species of hantavirus that is transmitted to humans primarily through contact with the infected urine or droppings of a deer mouse (Peromyscus maniculatus). Deer mice are present throughout most of the continental United States, but transmission is most common in the “Four Corners” region (Arizona, Colorado, New Mexico, and Utah) (1–3). The average incubation period is 1–5 weeks after exposure. There is no human-to-human transmission of SNV, and clustering of cases is uncommon. The patient did not report any known contact with rodents, rodent nests, or rodent droppings either in his places of lodging or during the course of his recreational activities.
An environmental investigation conducted by the Arizona Department of Health Services and the Utah Department of Health did not find any evidence of rodent infestation at the inns and hotels where the patient and his family stayed during their travels. In Antelope Cave, evidence of rodent burrowing was identified in areas around the canyon entrances as well as at the juncture of the canyon floor and walls. In addition, tour guides are known to throw sand from the canyon floor into the air to better illuminate the sunlight beams entering the canyon for photography, which could expose visitors to aerosolized rodent feces.
This case represents the first confirmed instance of SNV infection exported from the United States. Although no clear source of the patient’s exposure was found, it likely occurred during the course of his recreational outdoor activities. Clinicians and public health practitioners should be aware of hantavirus pulmonary syndrome as a potential illness among travelers returning from the southwestern United States. Travelers to this region of the United States should also be informed of the risk factors for hantavirus exposure and methods for risk reduction through public health education materials at popular tourist sites, and tour guide operators should be encouraged to leave the canyon floor undisturbed during their programs.
Corresponding author: Aaron Kofman, email@example.com, 404-639-8257.
1Epidemic Intelligence Service, CDC; 2Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 3Sheba Medical Center, Tel Hashomer, Israel; 4Sackler Medical School, Tel Aviv University, Israel; 5Navajo Department of Health, Window Rock, Arizona; 6Arizona Department of Health Services; 7Utah Department of Health; 8Nevada Department of Health and Human Services; 9Northern Arizona Healthcare, Flagstaff, Arizona; 10Coconino County Public Health Services District, Flagstaff, Arizona; 11National Park Service, Washington, DC.
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No disclosures were reported.
- Knust B, Rollin PE. Twenty-year summary of surveillance for human hantavirus infections, United States. Emerg Infect Dis 2013;19:1934–7. CrossRefexternal icon PubMedexternal icon
- CDC. Hantavirus disease, by state of exposure. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/hantavirus/surveillance/state-of-exposure.html
- Childs JE, Ksiazek TG, Spiropoulou CF, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994;169:1271–80. CrossRefexternal icon PubMedexternal icon
Suggested citation for this article: Kofman A, Rahav G, Yazzie D, et al. Notes from the Field: Exported Case of Sin Nombre Hantavirus Pulmonary Syndrome — Israel, 2017. MMWR Morb Mortal Wkly Rep 2018;67:1129. DOI: http://dx.doi.org/10.15585/mmwr.mm6740a5external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.